Literature DB >> 22648618

Annatto prevents retinal degeneration induced by endoplasmic reticulum stress in vitro and in vivo.

Kazuhiro Tsuruma1, Hiroki Shimazaki, Ken-Ichi Nakashima, Mika Yamauchi, Sou Sugitani, Masamitsu Shimazawa, Munekazu Iinuma, Hideaki Hara.   

Abstract

SCOPE: Annatto (Bixa orellana) seeds have been used as a colorant in butter and in a variety of other foods. In this study, we investigated the amelioration of retinal damage by an acetone extract of annatto (A-ext.), bixin (a main component of annatto), and four bixin derivatives (Bx-1, Bx-2, Bx-3, and Bx-4) that we have synthesized. METHODS AND
RESULTS: We used cultured retinal ganglion cells (RGC-5) to examine in vitro effects of A-ext. on stress pathways, focusing on intracellular oxidation induced by reactive oxygen species, expression of endoplasmic reticulum (ER) stress-related proteins, caspase-3 activation, and cell membrane damage. In vivo retinal damage in mice following intravitreous injection of tunicamycin was evaluated by counting the cell numbers in the ganglion cell layer (GCL) and measuring the thickness of outer nuclear layer (ONL). A-ext., bixin, and Bx-1 treatment inhibited both tunicamycin- and H₂O₂-induced cell death. Bixin derivatives also inhibited tunicamycin-induced cell death. Treatment with A-ext., bixin, and Bx-1 reduced tunicamycin-induced caspase-3 activity and inhibited the inversion of phosphatidylserine, an early apoptotic event without antioxidant effect or reduction of ER stress itself. A-ext., bixin, and Bx-1 significantly inhibited the tunicamycin-induced loss of cells from the GCL, and these materials also suppressed the tunicamycin-induced thinning of ONL.
CONCLUSION: A-ext., its main component bixin, and bixin derivatives may therefore be useful for preventive and therapeutic treatment of retinal-related diseases.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648618     DOI: 10.1002/mnfr.201100607

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  6 in total

1.  An activated unfolded protein response promotes retinal degeneration and triggers an inflammatory response in the mouse retina.

Authors:  T Rana; V M Shinde; C R Starr; A A Kruglov; E R Boitet; P Kotla; S Zolotukhin; A K Gross; M S Gorbatyuk
Journal:  Cell Death Dis       Date:  2014-12-18       Impact factor: 8.469

2.  Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo.

Authors:  Valérie Fontaine; Elodie Monteiro; Elena Brazhnikova; Laëtitia Lesage; Christine Balducci; Louis Guibout; Laurence Feraille; Pierre-Paul Elena; José-Alain Sahel; Stanislas Veillet; René Lafont
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

3.  Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress.

Authors:  Orie Nakamura; Satoru Moritoh; Kota Sato; Shigeto Maekawa; Namie Murayama; Noriko Himori; Kazuko Omodaka; Tetsuya Sogon; Toru Nakazawa
Journal:  Clin Ophthalmol       Date:  2017-10-11

Review 4.  Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors.

Authors:  Serge Camelo; Mathilde Latil; Stanislas Veillet; Pierre J Dilda; René Lafont
Journal:  Oxid Med Cell Longev       Date:  2020-12-08       Impact factor: 6.543

Review 5.  Cellular stress signaling and the unfolded protein response in retinal degeneration: mechanisms and therapeutic implications.

Authors:  Todd McLaughlin; Andy Medina; Jacob Perkins; Maria Yera; Joshua J Wang; Sarah X Zhang
Journal:  Mol Neurodegener       Date:  2022-03-28       Impact factor: 14.195

6.  Protective effects of bilberry and lingonberry extracts against blue light-emitting diode light-induced retinal photoreceptor cell damage in vitro.

Authors:  Kenjirou Ogawa; Yoshiki Kuse; Kazuhiro Tsuruma; Saori Kobayashi; Masamitsu Shimazawa; Hideaki Hara
Journal:  BMC Complement Altern Med       Date:  2014-04-02       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.